Chemotherapeutic Toxicity: Clinical Trials

10 trials for Chemotherapeutic Toxicity, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

6 unknown, 2 completed, 2 not yet recruiting. 10 Phase 2, 1 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 210Unknown 6, Completed 2, Not yet recruiting 2
Phase 31Unknown 1

Follow Chemotherapeutic Toxicity: new trials by email Literature Review of Chemotherapeutic Toxicity trials Research Report on Chemotherapeutic Toxicity

Trials (filtered) newest first · largest first

All 10 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Herombopag for the Prevention of Radio-chemotherapy Induced Thrombocytopenia in Cervical Cancer
herombopag - Thrombopenia, Cervical Cancer
Phase 2Not yet recruitingPeking University Cancer Hospital & Institute302025-01-012024-12-20
Semaglutide in Auto-HSCT
Semaglutide Pen Injector [Ozempic], Placebo - Intestinal Mucositis, Inflammation
Phase 2Not yet recruitingKlaus Gottlob Müller402024-08-122024-06-10
Coenzyme Q10 and Chemotherapeutic Toxicity in Breast Cancer Patients
Placebo, Coenzyme Q10 200mg twice daily - Breast Cancer, Chemotherapeutic Toxicity
Phase 2CompletedDamanhour University402024-08-012025-12-26
The Efficacy and Safety of Docetaxel Combined With Platinum for Metastatic Hormone-sensitive Prostate Cancer
Docetaxel, Prednisolone Acetate, Platinum-based drugs - Hormone Sensitive Metastatic Prostate Cancer, DNA Damage Repair Deficiency
Phase 2UnknownThe Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School502022-07-012022-10-24
Clinical Study of Xinmailong Injection on Reducing Cardiovascular Toxicity in Adjuvant Chemotherapy in Breast Cancer
Xinmailong Injection - Breast Neoplasms, Cardiac Event
Phase 2UnknownPeking Union Medical College602019-01-012020-01-22
Prophylactic Gabapentin for Taxane-Induced Arthralgia and Myalgia Syndrome in Breast Cancer Patients Undergoing Adjuvant Chemotherapy
Gabapentin 300mg - Invasive Breast Cancer, Chemotherapeutic Toxicity
Phase 2 / Phase 3UnknownBritish Columbia Cancer Agency462018-07-022018-06-25
A Study of Apatinib Treatment in for Advanced Ovarian Cancer
Apatinib, Taxus + platinum - Ovarian Cancer, Chemotherapeutic Toxicity
Phase 2UnknownThe People's Hospital of Leshan342017-08-012018-01-16
Apatinib Plus XELOX as Neoadjuvant Therapy in Locally Advanced Gastric Cancer
Apatinib plus XELOX - Chemotherapy Effect, Chemotherapeutic Toxicity
Phase 2UnknownShanghai Zhongshan Hospital352017-02-012019-06-28
Treatment of Peritoneal Carcinomatosis With Pressurized IntraPeritoneal Aerosol Chemotherapy -
PIPAC - Peritoneum; Carcinomatosis, Peritoneal Neoplasms
Phase 2CompletedMichael Bau Mortensen1432016-12-012022-10-07
Intraperitoneal and System Chemotherapy Versus XELOX as First-line Chemotherapy for mCRC
Irinotecan, Oxaliplatin, Capecitabine - Colorectal Cancer Metastatic, Chemotherapy Effect
Phase 2UnknownThe Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School1002016-01-012019-01-03

Narrower conditions

Breast Neoplasms (2)  ·  Arthralgia (1)  ·  Cardiovascular Diseases (1)  ·  Inflammation (1)  ·  Myalgia (1)  ·  Ovarian Neoplasms (1)  ·  Peritoneal Neoplasms (1)  ·  Radiation Injuries (1)  ·  Stomach Neoplasms (1)  ·  Thrombocytopenia (1)  ·  Uterine Cervical Neoplasms (1)

Broader conditions

Neoplasms (6)  ·  Neoplasms by Site (6)  ·  Breast Diseases (2)  ·  Digestive System Diseases (2)  ·  Digestive System Neoplasms (2)  ·  Female Urogenital Diseases (2)  ·  Female Urogenital Diseases and Pregnancy Complications (2)  ·  Genital Diseases (2)  ·  Genital Diseases, Female (2)  ·  Genital Neoplasms, Female (2)  ·  Pathological Conditions, Signs and Symptoms (2)  ·  Skin Diseases (2)  ·  Skin and Connective Tissue Diseases (2)  ·  Urogenital Diseases (2)  ·  Urogenital Neoplasms (2)

Interventions

Oxaliplatin (2)  ·  apatinib (2)  ·  Capecitabine (1)  ·  Cisplatin (1)  ·  Docetaxel (1)  ·  Doxorubicin (1)  ·  Gabapentin (1)  ·  Irinotecan (1)  ·  Platinum (1)  ·  XELOX (1)  ·  coenzyme Q10 (1)  ·  prednisolone acetate (1)  ·  semaglutide (1)  ·  ubiquinol (1)  ·  xinmailong (1)

Sponsors

The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School (2)  ·  British Columbia Cancer Agency (1)  ·  Damanhour University (1)  ·  Klaus Gottlob Müller (1)  ·  Michael Bau Mortensen (1)  ·  Peking Union Medical College (1)  ·  Peking University Cancer Hospital & Institute (1)  ·  Shanghai Zhongshan Hospital (1)  ·  The People's Hospital of Leshan (1)

Countries

China (6)  ·  Denmark (1)  ·  Egypt (1)

Top investigators

Ahmed Ashour, PhD (1)  ·  Amira B Kassem, PhD (1)  ·  Gehad Hassoub, Bachelor (1)  ·  Hongqian Guo (1)  ·  Jing Jing (1)  ·  Noha Ahmed El Bassiouny, PhD (1)  ·  Xiaofan Li, Dr (1)  ·  Yasser Abdelkader (1)

Results publications

PMID 19144680, PMID 20110050, PMID 2110385, PMID 26187614, PMID 29248399, PMID 29622384, PMID 30156363, PMID 30764783, PMID 30911656, PMID 30911669, PMID 30915164, PMID 33632264, PMID 35382819, PMID 39384243, PMID 42401951, PMID 8201386, PMID 9043028